查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954232

肥胖管理市场分析及预测（至2035年）：依类型、产品、服务、技术、组件、应用、最终用户、设备、解决方案划分

Obesity Management Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Device, Solutions
出版日期: | 出版商: Global Insight Services | 英文 391 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，全球肥胖管理市场规模将从2024年的25亿美元成长至40亿美元，年复合成长率约为5.3%。该市场涵盖旨在预防、诊断和治疗肥胖的各种服务和产品，包括药物、外科手术、营养补充剂和生活方式干预。全球肥胖率的上升推动了对结合医疗、营养和行为方法的创新体重管理解决方案的需求。市场成长的驱动因素包括公众意识的提高、医疗技术的进步以及政府的支持，这些因素共同促进了个人化治疗方案和技术主导型介入措施的发展。

肥胖管理市场正经历强劲成长，这主要得益于人们对有效体重管理方案日益增长的认知和需求。在该市场中，药物治疗细分市场成长最为显着，这主要得益于针对肥胖症的先进药物的研发。减重手术紧随其后，体现了其在显着减轻体重和改善健康方面的有效性。行为疗法细分市场也呈现成长势头，强调生活方式调整和心理支持的重要性。数位健康平台和穿戴式装置等创新技术增强了患者的参与度和监测能力，从而促进了市场扩张。代餐产品和营养补充品为体重管理提供了便利且个人化的解决方案，因此越来越受欢迎。远端医疗服务的整合进一步便利了肥胖管理计画的普及，尤其是在偏远地区。这些因素的汇聚凸显了肥胖管理的综合性方法，并为这个充满活力的市场中的相关人员提供了丰厚的机会。

市场区隔
类型 药物疗法、外科手术器械、非侵入性器械、营养补充剂、行为疗法
产品 处方药和非处方药、食慾抑制剂、脂肪吸收抑制剂和代谢加速剂
服务 减重计画、咨询服务、营养服务、健身计画、减重手术
科技 穿戴式装置、行动应用、远端医疗、人工智慧、虚拟现实
成分 软体、硬体和服务
目的 医院使用、居家照护、诊所、健身中心、研究机构
最终用户 成人、儿童、老人、运动员、企业员工
装置 胃束带、胃内球囊、电刺激设备、胃内球囊
解决方案 综合体重管理、生活型态改变、手术介入和药物治疗

肥胖管理市场以产品组合多元化为特征，尤其重视创新解决方案。随着企业寻求透过价值主导提案来获取市场份额，定价策略的竞争日益激烈。近期推出的产品反映出市场正朝着整合式健康管理解决方案的方向发展，并专注于个人化、全面性的方法。这种动态的市场格局凸显了适应性和创新性在维持竞争优势的重要性。竞争基准分析显示，市场由少数几家主要企业主导，这些企业不断透过策略联盟和收购来强化产品系列。监管影响至关重要，严格的指导方针影响产品开发和打入市场策略。在监管核准和消费者对非侵入性治疗方案偏好的推动下，对非侵入性治疗方法的需求正在激增。大量新型疗法的开发平臺以及对生活方式干预项目的日益重视表明，该市场具有持续增长的潜力。

主要趋势和驱动因素：

受全球肥胖盛行率上升和健康意识增强的推动，肥胖管理市场正经历蓬勃发展。关键趋势包括数位健康技术的融合，例如行动应用程式和穿戴式设备，这些技术能够提供个人化的体重管理解决方案。这些技术使个人能够监测自身进展并做出明智的生活方式选择，从而提高患者的参与度。製药业的进步也发挥关键作用，新型抗肥胖药物不断涌入市场。这些药物为那些努力减重的人带来了新的希望，并且与生活方式的改变相结合，能够提供有效的治疗方案。此外，人们越来越关注减重手术作为治疗重度肥胖的有效手段，这也促进了市场的扩张。公共和私营部门对综合性肥胖预防项目的投资进一步推动了市场成长。在医疗基础设施正在发展的未来地区，随着宣传宣传活动的开展，新的机会正在涌现。专注于创新且经济高效的解决方案的公司将占据新兴市场的优势地位。技术、医学和公共卫生措施的整合预计将推动肥胖管理市场的发展，并加速应对这一重大的全球健康挑战。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 药物治疗
    • 外科器械
    • 非侵入式设备
    • 营养补充品
    • 行为疗法
  • 市场规模及预测：依产品划分
    • 处方药
    • 非处方药
    • 食慾抑制剂
    • 脂肪吸收抑制剂
    • 代谢加速器
  • 市场规模及预测：依服务划分
    • 减重计画
    • 咨询服务
    • 营养服务
    • 健身计划
    • 减重手术
  • 市场规模及预测：依技术划分
    • 穿戴式装置
    • 行动应用
    • 远端医疗
    • 人工智慧
    • 虚拟实境
  • 市场规模及预测：依组件划分
    • 软体
    • 硬体
    • 服务
  • 市场规模及预测：依应用领域划分
    • 医院用途
    • 居家照护
    • 诊所
    • 健身中心
    • 研究所
  • 市场规模及预测：依最终用户划分
    • 成人
    • 儿童
    • 老年人
    • 运动员
    • 企业员工
  • 市场规模及预测：依设备划分
    • 胃束带
    • 胃内球囊
    • 电刺激设备
    • 胃内球囊
  • 市场规模及预测：按解决方案划分
    • 综合体重管理
    • 生活方式改善
    • 手术介入
    • 药物治疗

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Novo Nordisk
  • Eisai
  • Arena Pharmaceuticals
  • Orexigen Therapeutics
  • Vivus
  • Zafgen
  • Rhythm Pharmaceuticals
  • Soleno Therapeutics
  • 9 Meters Biopharma
  • Altimmune
  • Gelesis
  • Sorrento Therapeutics
  • Astra Zeneca
  • Pfizer
  • Boehringer Ingelheim
  • Amgen
  • Alnylam Pharmaceuticals
  • Bristol Myers Squibb
  • Takeda Pharmaceutical
  • Lilly

第九章：关于我们

简介目录
Product Code: GIS32425

Obesity Management Market is anticipated to expand from $2.5 billion in 2024 to $4.0 billion by 2034, growing at a CAGR of approximately 5.3%. The Obesity Management Market encompasses a range of services and products aimed at preventing, diagnosing, and treating obesity. This includes pharmaceuticals, surgical procedures, dietary supplements, and lifestyle interventions. With rising global obesity rates, there is a growing demand for innovative solutions that combine medical, nutritional, and behavioral approaches to manage weight effectively. The market is driven by increasing awareness, healthcare advancements, and supportive government initiatives, fostering opportunities for growth and development in personalized treatment plans and technology-driven interventions.

The Obesity Management Market is experiencing robust growth, fueled by increasing awareness and demand for effective weight management solutions. Within this market, the pharmacotherapy segment stands out as the top-performing sub-segment, driven by the development of advanced medications targeting obesity. Bariatric surgery follows closely, reflecting its effectiveness in achieving significant weight loss and health improvements. The behavioral therapy sub-segment is also gaining momentum, emphasizing the importance of lifestyle changes and psychological support. Innovative technologies, such as digital health platforms and wearable devices, are enhancing patient engagement and monitoring, contributing to the market's expansion. Meal replacement products and dietary supplements are witnessing increased adoption, offering convenient and personalized solutions for weight management. The integration of telehealth services is further facilitating access to obesity management programs, particularly in remote areas. The convergence of these elements underscores a comprehensive approach to obesity management, presenting lucrative opportunities for stakeholders in this dynamic market.

Market Segmentation
TypePharmacotherapy, Surgical Devices, Non-Invasive Devices, Dietary Supplements, Behavioral Therapy
ProductPrescription Drugs, Over-the-Counter Drugs, Appetite Suppressants, Fat Absorption Inhibitors, Metabolism Boosters
ServicesWeight Loss Programs, Counseling Services, Nutritional Services, Fitness Programs, Bariatric Surgery
TechnologyWearable Devices, Mobile Applications, Telemedicine, Artificial Intelligence, Virtual Reality
ComponentSoftware, Hardware, Services
ApplicationHospital Use, Home Care, Clinics, Fitness Centers, Research Institutes
End UserAdults, Pediatrics, Geriatrics, Athletes, Corporate Employees
DeviceGastric Bands, Gastric Balloons, Electrical Stimulation Devices, Intragastric Balloons
SolutionsComprehensive Weight Management, Lifestyle Modification, Surgical Intervention, Pharmacological Treatment

The Obesity Management Market is characterized by a diverse array of product offerings, with a notable emphasis on innovative solutions. Pricing strategies are becoming increasingly competitive, as companies strive to capture market share through value-driven propositions. Recent product launches have focused on personalized and holistic approaches, reflecting a shift towards integrated health management solutions. This dynamic landscape underscores the importance of adaptability and innovation in maintaining a competitive edge. In terms of competition benchmarking, the market is dominated by a few key players, who are continually enhancing their product portfolios through strategic alliances and acquisitions. Regulatory influences play a pivotal role, with stringent guidelines shaping product development and market entry strategies. The market is witnessing a surge in demand for non-invasive treatments, driven by regulatory approvals and consumer preference for less intrusive options. The robust pipeline of novel therapeutics and the growing emphasis on lifestyle intervention programs highlight the market's potential for sustained growth.

Geographical Overview:

The obesity management market is witnessing notable growth across various regions, each presenting unique opportunities. North America dominates the market, driven by high obesity rates and increasing public awareness. Government initiatives and healthcare policies support the adoption of obesity management solutions, further propelling the market. Europe follows, with rising health consciousness and robust healthcare infrastructure enhancing market prospects. The region's focus on preventive healthcare and wellness programs contributes to its growth. In the Asia Pacific, the market is expanding rapidly due to urbanization, lifestyle changes, and increasing disposable incomes. Emerging economies like China and India are investing heavily in healthcare, creating lucrative opportunities. Latin America and the Middle East & Africa are emerging markets with significant potential. In Latin America, rising obesity rates and growing healthcare investments are driving demand. Meanwhile, the Middle East & Africa are focusing on improving healthcare access and infrastructure, recognizing the importance of obesity management in public health.

The global obesity management market is increasingly influenced by tariffs, geopolitical tensions, and evolving supply chain dynamics, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are investing in local production capabilities to mitigate tariff impacts and ensure supply chain resilience. China is focusing on self-reliance, driven by trade tensions and a robust domestic market demand. Taiwan remains pivotal in medical technology manufacturing but is vulnerable to geopolitical risks. The parent market is experiencing steady growth, driven by rising obesity rates and a shift towards holistic health solutions. By 2035, market evolution will hinge on innovation, strategic alliances, and supply chain agility. Middle East conflicts could exacerbate energy costs, affecting production and distribution logistics globally.

Key Trends and Drivers:

The obesity management market is experiencing dynamic growth, driven by rising obesity prevalence and increasing health awareness globally. Key trends include the integration of digital health technologies, such as mobile apps and wearable devices, which facilitate personalized weight management solutions. These technologies empower individuals to monitor their progress and make informed lifestyle choices, thereby enhancing patient engagement. Pharmaceutical advancements are also playing a pivotal role, with novel anti-obesity drugs entering the market. These medications offer new hope for individuals struggling with weight loss, providing effective options when combined with lifestyle changes. Furthermore, the growing emphasis on bariatric surgeries as a viable intervention for severe obesity is contributing to market expansion. Public and private sectors are investing in comprehensive obesity prevention programs, further driving market growth. Opportunities exist in developing regions where healthcare infrastructure is improving, and awareness campaigns are gaining traction. Companies focusing on innovative, cost-effective solutions are well-positioned to capture emerging markets. The convergence of technology, pharmaceuticals, and public health initiatives is set to propel the obesity management market forward, addressing a critical global health challenge.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Device
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Pharmacotherapy
    • 4.1.2 Surgical Devices
    • 4.1.3 Non-Invasive Devices
    • 4.1.4 Dietary Supplements
    • 4.1.5 Behavioral Therapy
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Prescription Drugs
    • 4.2.2 Over-the-Counter Drugs
    • 4.2.3 Appetite Suppressants
    • 4.2.4 Fat Absorption Inhibitors
    • 4.2.5 Metabolism Boosters
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Weight Loss Programs
    • 4.3.2 Counseling Services
    • 4.3.3 Nutritional Services
    • 4.3.4 Fitness Programs
    • 4.3.5 Bariatric Surgery
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Wearable Devices
    • 4.4.2 Mobile Applications
    • 4.4.3 Telemedicine
    • 4.4.4 Artificial Intelligence
    • 4.4.5 Virtual Reality
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Hospital Use
    • 4.6.2 Home Care
    • 4.6.3 Clinics
    • 4.6.4 Fitness Centers
    • 4.6.5 Research Institutes
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Adults
    • 4.7.2 Pediatrics
    • 4.7.3 Geriatrics
    • 4.7.4 Athletes
    • 4.7.5 Corporate Employees
  • 4.8 Market Size & Forecast by Device (2020-2035)
    • 4.8.1 Gastric Bands
    • 4.8.2 Gastric Balloons
    • 4.8.3 Electrical Stimulation Devices
    • 4.8.4 Intragastric Balloons
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Comprehensive Weight Management
    • 4.9.2 Lifestyle Modification
    • 4.9.3 Surgical Intervention
    • 4.9.4 Pharmacological Treatment

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Device
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Device
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Device
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Device
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Device
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Device
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Device
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Device
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Device
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Device
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Device
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Device
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Device
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Device
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Device
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Device
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Device
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Device
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Device
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Device
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Device
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Device
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Device
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Device
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Novo Nordisk
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Eisai
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Arena Pharmaceuticals
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Orexigen Therapeutics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Vivus
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Zafgen
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Rhythm Pharmaceuticals
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Soleno Therapeutics
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 9 Meters Biopharma
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Altimmune
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Gelesis
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Sorrento Therapeutics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Astra Zeneca
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Pfizer
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Boehringer Ingelheim
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Amgen
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Alnylam Pharmaceuticals
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Bristol Myers Squibb
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Takeda Pharmaceutical
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Lilly
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us